-Amyloid Disrupting Drugs: Potential in the Treatment of Alzheimer's Disease

By Soto C.  

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Drugs with anticholinergic properties: a current perspective on use and safety

By Gerretsen Philip   Pollock Bruce G  

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 751-765

Informa Healthcare

Access to resources Recommend Favorite

Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease

By  

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 842-852

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease

By Lockwood Peter   Ewy Wayne   Hermann David   Holford Nick  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2050-2059

Springer Publishing Company

Access to resources Recommend Favorite

Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer's Disease: Potential for Pharmacological Intervention

By Kivipelto M.  

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 435-444

Adis International

Access to resources Recommend Favorite